Our Services
Medical Information
Helpful Resources
Published on: 9/28/2026
Valsartan, an angiotensin receptor blocker used for high blood pressure and heart failure, commonly causes dizziness, lightheadedness when standing, headache, fatigue, and sometimes elevated potassium or reduced kidney function. Warning signs that need urgent attention include swelling of the face, lips, or throat, trouble breathing, fainting, little or no urination, an irregular heartbeat, or muscle weakness, and the drug should never be taken during pregnancy. Several factors influence which symptoms matter most for you, including your dose, kidney health, and other medications such as diuretics, potassium supplements, or NSAIDs, so see below for the full details before deciding what to do next.
Because dizziness, fatigue, and swelling can stem from your medication, your blood pressure itself, or an unrelated condition, sorting out the cause quickly matters. Take a free, instant, online symptom check to better understand what may be driving your symptoms and what step to take next.
Last reviewed for medical accuracy: 09/28/2026
Valsartan is an angiotensin II receptor blocker (ARB) commonly prescribed for high blood pressure and heart failure. Like all medications, it can cause side effects. Understanding the difference between common, mild reactions and warning signs of serious problems helps you stay informed and proactive about your health.
Valsartan relaxes blood vessels by blocking the effects of angiotensin II, a hormone that narrows arteries. This helps:
People with high blood pressure, heart failure, or certain types of heart injury often take valsartan to reduce their risk of complications such as stroke, heart attack, or hospitalization.
Many people tolerate valsartan well. The most frequently reported side effects are generally mild and may decrease over time:
These side effects often appear during the first few weeks and improve as your body adjusts. If they persist or worsen, talk to your doctor. Small adjustments—like taking valsartan at bedtime—can sometimes help.
While rare, more serious reactions do occur. Be aware of these less common valsartan side effects:
If you notice any of these, monitor your symptoms closely. Dehydration from diarrhea or vomiting can worsen kidney function, especially when taking blood pressure–lowering medications.
Some valsartan side effects can be life threatening. Seek immediate medical attention if you experience:
These symptoms may indicate an allergic reaction, heart attack, or stroke. Do not wait to see if they resolve on their own.
You can often manage mild valsartan side effects with simple strategies:
Always discuss any lifestyle or dosing changes with your healthcare provider before implementing them.
Valsartan can affect kidney function and potassium levels. Your doctor will likely order periodic blood tests to check:
Signs of kidney issues or electrolyte imbalance include:
Report these symptoms promptly to avoid complications.
If you’re unsure whether your symptoms are normal or concerning, take immediate action:
Early identification of problems can prevent emergency situations and help your healthcare team fine-tune your treatment.
Open communication with your medical team leads to safer, more effective treatment.
Understanding valsartan side effects empowers you to take control of your treatment and health. Mild symptoms are common and often manageable. But always stay alert for warning signs that require urgent care. If you have any doubts, speak to a doctor—your safety comes first.
Remember, a free, online symptom check, using the doctor approved Ubie Symptom Checker, can offer fast, reliable triage and help you decide next steps. https://ubiehealth.com/
Stay informed, stay proactive, and keep your healthcare team in the loop for the best possible outcomes.
(References)
* Gómez NA, Mejillón JL, Zapatier JA, Vargas PE. [Biliary stenosis, hepatitis A and valsartan: multifactorial hepatotoxicity in a surgical patient]. Cir Esp. 2006 Mar;79(3):189-91. doi: 10.1016/s0009-739x(06)70849-1. PMID: 16545288.
* Tummala R, Bhadra R, Gupta A, Ghosh RK. Combined Neprilysin and RAS Inhibition in Cardiovascular Diseases: A Review of Clinical Studies. J Cardiovasc Pharmacol. 2016 Sep;68(3):183-90. doi: 10.1097/FJC.0000000000000402. PMID: 27092662.
* De Vecchis R, Ariano C, Di Biase G, Noutsias M. Sacubitril/valsartan for heart failure with reduced left ventricular ejection fraction : A retrospective cohort study. Herz. 2019 Aug;44(5):425-432. doi: 10.1007/s00059-017-4671-1. Epub 2018 Jan 19. PMID: 29350254.
* Balmforth C, Simpson J, Shen L, Jhund PS, Lefkowitz M, Rizkala AR, Rouleau JL, Shi V, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV. Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF. JACC Heart Fail. 2019 Jun;7(6):457-465. doi: 10.1016/j.jchf.2019.02.015. Epub 2019 May 8. PMID: 31078482.
* Barry AR, Lee C. Pharmacist- or Nurse Practitioner-Led Assessment and Titration of Sacubitril/Valsartan in a Heart Failure Clinic: A Cohort Study. Can J Hosp Pharm. 2020 May-Jun;73(3):186-192. Epub 2020 Jun 1. PMID: 32616944; PMCID: PMC7308157.
* Halimi JM. [SGLT2 inhibitors: A new era for our patients]. Nephrol Ther. 2021 Jun;17(3):143-148. doi: 10.1016/j.nephro.2020.12.006. Epub 2021 Mar 25. PMID: 33773943.
* Charuel E, Menini T, Bedhomme S, Pereira B, Piñol-Domenech N, Bouchant S, Boussageon R, Bœuf-Gibot S, Vaillant-Roussel H. Benefits and adverse effects of sacubitril/valsartan in patients with chronic heart failure: A systematic review and meta-analysis. Pharmacol Res Perspect. 2021 Oct;9(5):e00844. doi: 10.1002/prp2.844. PMID: 34617669; PMCID: PMC8495680.
* Drugs for chronic heart failure. Med Lett Drugs Ther. 2025 May 26;67(1729):81-88. doi: 10.58347/tml.2025.1729a. PMID: 40388632.
* Rudolph J, von Haehling S. [Heart failure in Germany: epidemiology and recent developments]. Dtsch Med Wochenschr. 2025 Nov;150(22):1341-1348. doi: 10.1055/a-2502-2024. Epub 2025 Oct 28. PMID: 41151613.
* Kraft BD, Matuszak S. Angioedema After Accidental Semaglutide Dosing Error: A Case Report. J Clin Med. 2026 May 12;15(10). doi: 10.3390/jcm15103705. Epub 2026 May 12. PMID: 42194666; PMCID: PMC13207423.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.